Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.83M Buy
102,993
+1,162
+1% +$112K 0.01% 550
2026
Q1
$10.6M Sell
101,831
-1,650
-2% -$187K 0.02% 524
2025
Q4
$10.4M Buy
103,481
+5,529
+6% +$600K 0.02% 539
2025
Q3
$12.1M Buy
97,952
+5,749
+6% +$714K 0.02% 493
2025
Q2
$11.1M Buy
92,203
+4,396
+5% +$586K 0.02% 500
2025
Q1
$12.9M Buy
87,807
+13,214
+18% +$2.02M 0.03% 414
2024
Q4
$12.1M Sell
74,593
-112,685
-60% -$18.4M 0.03% 407
2024
Q3
$30.5M Buy
187,278
+4,609
+3% +$683K 0.08% 285
2024
Q2
$24.9M Buy
182,669
+56,498
+45% +$7.85M 0.07% 308
2024
Q1
$19.3M Buy
126,171
+65,816
+109% +$9.82M 0.06% 345
2023
Q4
$8.61M Buy
60,355
+46,033
+321% +$6.14M 0.03% 460
2023
Q3
$1.88M Sell
14,322
-18,792
-57% -$2.86M 0.01% 621
2023
Q2
$5.27M Sell
33,114
-224,581
-87% -$36.2M 0.02% 506
2023
Q1
$40.8M Buy
257,695
+79,657
+45% +$11.9M 0.18% 130
2022
Q4
$25M Buy
178,038
+37,312
+27% +$5.3M 0.12% 227
2022
Q3
$18.1M Buy
140,726
+35,704
+34% +$5.15M 0.1% 263
2022
Q2
$14.8M Buy
105,022
+29,903
+40% +$4.27M 0.08% 352
2022
Q1
$10.4M Buy
75,119
+33,455
+80% +$5.13M 0.05% 423
2021
Q4
$7.26M Buy
41,664
+4,088
+11% +$681K 0.03% 485
2021
Q3
$6.22M Sell
37,576
-24,195
-39% -$4.17M 0.03% 514
2021
Q2
$11.1M Buy
61,771
+12,823
+26% +$2.34M 0.05% 364
2021
Q1
$9.44M Sell
48,948
-668
-1% -$129K 0.05% 348
2020
Q4
$10M Sell
49,616
-1,873
-4% -$388K 0.05% 323
2020
Q3
$10.8M Sell
51,489
-864
-2% -$192K 0.06% 262
2020
Q2
$11.5M Sell
52,353
-12,353
-19% -$2.47M 0.07% 238
2020
Q1
$11.2M Buy
64,706
+7,545
+13% +$1.25M 0.08% 206
2019
Q4
$8.78M Buy
57,161
+12,627
+28% +$1.89M 0.05% 314
2019
Q3
$6.76M Sell
44,534
-2,888
-6% -$457K 0.05% 339
2019
Q2
$7.26M Sell
47,422
-1,112
-2% -$170K 0.05% 350
2019
Q1
$7.79M Buy
48,534
+440
+0.9% +$68.3K 0.05% 330
2018
Q4
$7.41M Sell
48,094
-14,196
-23% -$2.21M 0.06% 326
2018
Q3
$9.37M Sell
62,290
-2,773
-4% -$394K 0.05% 347
2018
Q2
$8.8M Sell
65,063
-783
-1% -$96.7K 0.05% 344
2018
Q1
$8.77M Sell
65,846
-119,162
-64% -$16M 0.05% 333
2017
Q4
$27.5M Sell
185,008
-18,020
-9% -$2.45M 0.16% 149
2017
Q3
$26.8M Buy
203,028
+4,536
+2% +$609K 0.14% 160
2017
Q2
$26.5M Sell
198,492
-8,650
-4% -$1.17M 0.15% 160
2017
Q1
$27.9M Buy
207,142
+122,927
+146% +$15.9M 0.16% 146
2016
Q4
$10.1M Buy
84,215
+4,571
+6% +$539K 0.06% 330
2016
Q3
$9.97M Buy
79,644
+2,095
+3% +$274K 0.06% 337
2016
Q2
$10.7M Buy
77,549
+11,433
+17% +$1.48M 0.07% 296
2016
Q1
$8.34M Buy
66,116
+500
+0.8% +$63.6K 0.06% 339
2015
Q4
$8.32M Sell
65,616
-554
-0.8% -$68.8K 0.06% 332
2015
Q3
$7.64M Sell
66,170
-1,371
-2% -$154K 0.06% 337
2015
Q2
$7.03M Sell
67,541
-2,640
-4% -$285K 0.05% 392
2015
Q1
$7.75M Buy
70,181
+17,044
+32% +$1.85M 0.05% 400
2014
Q4
$5.54M Sell
53,137
-65
-0.1% -$6.5K 0.04% 436
2014
Q3
$5.11M Sell
53,202
-200
-0.4% -$18.1K 0.04% 479
2014
Q2
$4.88M Sell
53,402
-350
-0.7% -$31.3K 0.04% 496
2014
Q1
$4.73M Buy
53,752
+2,370
+5% +$208K 0.04% 479
2013
Q4
$4.77M Buy
51,382
+17,044
+50% +$1.54M 0.04% 469
2013
Q3
$2.81M Buy
34,338
+10,350
+43% +$874K 0.02% 601
2013
Q2
$1.99M Buy
+23,988
New +$2.06M 0.02% 613

Other funds holding CLX

Aviva's CLX Position: Q2 2026 in Review

Aviva increased its Clorox (CLX) stake by 1.1% in Q2 2026, buying an estimated $112K and bringing the position to 102,993 shares worth $9.83M. The position accounts for 0.01% of the portfolio, ranked #550.

Aviva first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $40.8M in Q1 2023. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Aviva held 102,993 shares of Clorox worth $9.83M as of Q2 2026.
  • Aviva bought 1,162 Clorox shares in Q2 2026, an estimated $112K.
  • Clorox made up 0.01% of Aviva's portfolio in Q2 2026, its #550 holding.
  • Aviva first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
  • Aviva's Clorox position peaked at $40.8M in Q1 2023.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.